PARAMUS, N.J., April 21, 2026 (GLOBE NEWSWIRE)-- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results